Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
367
-
Total 13F shares, excl. options
-
68.3M
-
Shares change
-
+236K
-
Total reported value, excl. options
-
$4.94B
-
Value change
-
+$7.51M
-
Put/Call ratio
-
0.63
-
Number of buys
-
172
-
Number of sells
-
-173
-
Price
-
$72.20
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2021
442 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q4 2021.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 367 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 68.3M shares
of 115M outstanding shares and own 59.3% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.51M shares), BlackRock Inc. (7.3M shares), JANUS HENDERSON GROUP PLC (6.53M shares), WELLINGTON MANAGEMENT GROUP LLP (3.22M shares), STATE STREET CORP (2.16M shares), Capital Research Global Investors (1.9M shares), Champlain Investment Partners, LLC (1.76M shares), RTW INVESTMENTS, LP (1.67M shares), AXA S.A. (1.67M shares), and KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.53M shares).
This table shows the top 367 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.